Preeclampsia (PE) is a specific syndrome of pregnancy, characterized by hypertension and proteinuria. This pathology is associated with hyperuricemia and elevated serum levels of inflammatory cytokines. Uric acid crystals may activate an intracellular complex called inflammasome, which is important for processing and release of inflammatory cytokines. This study investigated the state of monocyte activation, both endogenous and stimulated with monosodium urate (MSU), by gene expression of NLRP1 and NLRP3 receptors as well as their association with inflammatory cytokines expression. Monocytes were obtained from peripheral blood of 23 preeclamptic pregnant women, 23 normotensive pregnant women (NT) and 23 healthy non-pregnant women (NP). Infl...
Balanced immune responses are essential for the maintenance of successful pregnancy. Aberrant respon...
Preeclampsia (PE) affects 5-8% of pregnant women, and it is the major cause of perinatal morbidity a...
Preeclampsia (PE) affects 5% to 7% of pregnant women each year worldwide, accounts for up to 18% of ...
Preeclampsia (PE) is a specific syndrome of pregnancy, characterized by hypertension and proteinuria...
Preeclampsia (PE) is a human pregnancy-specific syndrome with abnormal activation of cells from the ...
Copyright © 2012 Cristina Catarino et al. This is an open access article distributed under the Creat...
Preeclampsia (PE) is a specific syndrome of pregnancy, characterized by hypertension and proteinuria...
ProblemTo evaluate associations between hyperuricemia and increases in production of reactive oxygen...
Problem High plasma levels of tumor necrosis factor-alpha (TNF-alpha) in pregnant women have been as...
Preeclampsia (PE) is a severe, acute disease of pregnancy affecting approximately 8% of pregnant wom...
<p>Monocytes from pregnant women with preeclampsia (PE), normotensive pregnant women (NT) and non-pr...
Introduction: Preeclampsia (PE) is characterized by an exaggerated systemic inflammatory response (...
Pre-eclampsia is a common disorder, specific to human pregnancy and a major cause of maternal and n...
Preeclampsia (PE) is a specific syndrome of human pregnancy, being one of the main causes of materna...
Introduction: this study is to determine the concentrations of IL-6, TNF α, and C reactive protein (...
Balanced immune responses are essential for the maintenance of successful pregnancy. Aberrant respon...
Preeclampsia (PE) affects 5-8% of pregnant women, and it is the major cause of perinatal morbidity a...
Preeclampsia (PE) affects 5% to 7% of pregnant women each year worldwide, accounts for up to 18% of ...
Preeclampsia (PE) is a specific syndrome of pregnancy, characterized by hypertension and proteinuria...
Preeclampsia (PE) is a human pregnancy-specific syndrome with abnormal activation of cells from the ...
Copyright © 2012 Cristina Catarino et al. This is an open access article distributed under the Creat...
Preeclampsia (PE) is a specific syndrome of pregnancy, characterized by hypertension and proteinuria...
ProblemTo evaluate associations between hyperuricemia and increases in production of reactive oxygen...
Problem High plasma levels of tumor necrosis factor-alpha (TNF-alpha) in pregnant women have been as...
Preeclampsia (PE) is a severe, acute disease of pregnancy affecting approximately 8% of pregnant wom...
<p>Monocytes from pregnant women with preeclampsia (PE), normotensive pregnant women (NT) and non-pr...
Introduction: Preeclampsia (PE) is characterized by an exaggerated systemic inflammatory response (...
Pre-eclampsia is a common disorder, specific to human pregnancy and a major cause of maternal and n...
Preeclampsia (PE) is a specific syndrome of human pregnancy, being one of the main causes of materna...
Introduction: this study is to determine the concentrations of IL-6, TNF α, and C reactive protein (...
Balanced immune responses are essential for the maintenance of successful pregnancy. Aberrant respon...
Preeclampsia (PE) affects 5-8% of pregnant women, and it is the major cause of perinatal morbidity a...
Preeclampsia (PE) affects 5% to 7% of pregnant women each year worldwide, accounts for up to 18% of ...